Literature DB >> 5346476

The sensitivity of a Yoshida sarcoma to methylene dimethane sulphonate.

B W Fox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5346476     DOI: 10.1002/ijc.2910040108

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters.

Authors:  J A Hartley; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde.

Authors:  P M O'Connor; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee).

Authors:  D B Smith; M J Lind; S B Kaye; E S Newlands; G R Blackledge; A Gibson
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

4.  A transferable "resistance factor" from in vitro cultured MDMS-resistant Yoshida sarcoma cells.

Authors:  B Szende; M Fox; B W Fox
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

5.  Electron spin resonance study of changes during development of solid yoshida tumour. II. Paramagnetic metal ions.

Authors:  N J Dodd; J M Silcock
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

6.  A study of the immunosuppressive activity of methylene dimethane sulphonate (MDMS) in relation to its effectiveness as an anti-tumour agent.

Authors:  B W Fox; C J Gregory
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640

7.  Electron spin resonance study of changes during development of solid Yoshida tumour. I: Ascorbyl radical.

Authors:  J M Silcock; N J Dodd
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.